Neurodegenerative and Age-Related Disorders
Focused on Developing Innovative Treatments
We’re committed to the development of disease-modifying therapies for age-related cognitive and neurodegenerative disorders.
the regulator of life and aging
Our α-Klotho Story
Today’s biologic medicines, like antibodies and recombinant proteins, are all derived from genetic materials. The DNA (gene) known to produce a therapeutic protein is inserted into a host cell, such as a bacteria or mammalian cells. The host cells then replicate and make the therapeutic protein. This is achieved using recombinant DNA technology developed in the late 1970’s and 1980’s. Biologic therapeutics are still made using this core technology.
Biologic & Gene Therapy
Our Products
We’re dedicated to realizing the potential of protein, cell and gene therapies to offer transformative patient outcomes in areas of high unmet medical need by extending the reach of protein, cell, and gene therapies to highly prevalent neurodegenerative disorders like amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease as they are universally fatal neurodegenerative and age-related disorders.
Press Releases
Latest News
Our Pipeline
Developing Life-Extending
Cell and Gene Therapies